Literature DB >> 10500489

Identification and quantification of cardiac glycosides in blood and urine samples by HPLC/MS/MS.

F Guan1, A Ishii, H Seno, K Watanabe-Suzuki, T Kumazawa, O Suzuki.   

Abstract

Cardiac glycosides (CG) are of forensic importance because of their toxicity and the fact that very limited methods are available for identification of CG in biological samples. In this study, we have developed an identification and quantification method for digoxin, digitoxin, deslanoside, digoxigenin, and digitoxigenin by high-performance liquid chromatography tandem mass spectrometry (HPLC/MS/MS). CG formed abundant [M + NH4]+ ions and much less abundant [M + H]+ ions as observed with electrospray ionization (ESI) source and ammonium formate buffer. Under mild conditions for collision-induced dissociation (CID), each [M + NH4]+ ion fragmented to produce a dominant daughter ion, which was essential to the sensitive method of selected reaction monitoring (SRM) quantification of CG achieved in this study. SRM was compared with selected ion monitoring (SIM) regarding the effects of sample matrixes on the methodology. SRM produced lower detection limits with biological samples than SIM, while both methods produced equal detection limits with CG standards. On the basis of the HPLC/MS/MS results for CG, we have proposed some generalized points for conducting sensitive SRM measurements, in view of the property of analytes as well as instrumental conditions such as the type of HPLC/MS interface and CID parameters. Analytes of which the molecular ion can produce one abundant daughter ion with high yield under CID conditions may be sensitively measured by SRM. ESI is the most soft ionization source developed so far and can afford formation of the fragile molecular ions that are necessary for sensitive SRM detection. Mild CID conditions such as low collision energy and low pressure of collision gas favor production of an abundant daughter ion that is essential to sensitive SRM detection. This knowledge may provide some guidelines for conducting sensitive SRM measurements of very low concentrations of drugs or toxicants in biological samples.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500489     DOI: 10.1021/ac990268c

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  Quantitative analysis of indole-3-acetic acid metabolites in Arabidopsis.

Authors:  M Kowalczyk; G Sandberg
Journal:  Plant Physiol       Date:  2001-12       Impact factor: 8.340

2.  Pharmacokinetics and pharmacodynamics of TF-505, a novel nonsteroidal 5alpha-reductase inhibitor, in normal subjects treated with single or multiple doses.

Authors:  Tomoe Fujita; Yoshiaki Matsumoto; Toshimi Kimura; Shinichi Yokota; Mika Sawada; Masataka Majima; Yoshio Ohtani; Yuji Kumagai
Journal:  Br J Clin Pharmacol       Date:  2002-09       Impact factor: 4.335

3.  LC-MS assay for quantitative determination of cardio glycoside in human blood samples.

Authors:  L Frommherz; H Köhler; B Brinkmann; M Lehr; J Beike
Journal:  Int J Legal Med       Date:  2007-06-14       Impact factor: 2.686

4.  Analysis of digoxin and metildigoxin in whole blood using solid-phase extraction and liquid chromatography tandem mass spectrometry.

Authors:  Paula Melo; Rita Machado; Helena M Teixeira
Journal:  Int J Anal Chem       Date:  2011-06-22       Impact factor: 1.885

5.  Electrochemically driven optical and SERS immunosensor for the detection of a therapeutic cardiac drug.

Authors:  Madeeha Chaudhry; Dong-Kwon Lim; Jeon Woong Kang; Zahid Yaqoob; Peter So; Muhammad Fahad Bhopal; Minqiang Wang; Raheel Qamar; Arshad Saleem Bhatti
Journal:  RSC Adv       Date:  2022-01-20       Impact factor: 3.361

6.  Development and Validation of a UHPLC-ESI-MS/MS Method for Quantification of Oleandrin and Other Cardiac Glycosides and Evaluation of Their Levels in Herbs and Spices from the Belgian Market.

Authors:  Svetlana V Malysheva; Patrick P J Mulder; Julien Masquelier
Journal:  Toxins (Basel)       Date:  2020-04-09       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.